Regeneron Files BPCIA Complaint Against Sandoz Regarding Aflibercept Biosimilar

September 3, 2024

Preliminary Injunction Issued Against Samsung Bioepis in Aflibercept BPCIA Litigation

June 17, 2024

Update on Aflibercept BPCIA Litigation

June 13, 2024

Genentech Files Lawsuits Against Biogen and Millennium for Past Royalties on the Cabilly Patents

March 3, 2023

Supreme Court Grants Cert to Address Enablement in Amgen Case

November 4, 2022

Regeneron Identifies Six Patents for Expedited Trial in BPCIA Aflibercept Case Against Mylan

October 31, 2022

Expedited Trial Ordered in Regeneron Aflibercept BPCIA Case Against Mylan

October 28, 2022

Celltrion’s Bevacizumab Biosimilar Approved by FDA

September 30, 2022

Regeneron Seeks Expedited Trial in BPCIA Case Against Mylan Regarding Aflibercept Biosimilar

September 13, 2022

Biogen Files Sealed Complaint Against Sandoz and Polpharma Biologics Regarding Natalizumab

September 12, 2022